retatrutide triple agonist obesity trial glp-1 gip glucagon phase 2 Ozempic targets one receptor. Tirzepatide 💉 Retatrutide may be redefining

The rationale for adding glucagon receptor agonism is the part that distinguishes it mechanistically

MHRA Urges Public to Avoid Illegal Online Weight-Loss Medicines

The Phase 2 trial (338 adults, 48 weeks) was published in the New England Journal of Medicine

There are a lot of people out there that could probably lose weight without GLP-1 drugs if they just discipline themselves and exercise more, but there is a segment of the population that cannot lose weight, and my daughter Alexa unfortunately falls within that category, Rich said

The exact amount should be individualized, especially if you have a medical condition or specific dietary considerations

Maintenance Strategy: Tools to preserve resultshabit coaching, labs, and (if helpful) targeted peptides during or after GLP-1 therapy